Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, ...

Sensydia Corp. reeled in $8 million in a financing round to advance its noninvasive Cardiac Performance System (CPS) platform, which uses heart sound analysis to enable earlier detection and better ...

LOS ANGELES--(BUSINESS WIRE)--Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal ...

A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...

Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of ...

Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as potentially ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

In a recent study published in Nature Communications, researchers from the United States of America investigated the association between platelet hyperreactivity and the risk of cardiovascular events.

Cardiovascular imaging, which continues to evolve alongside interventions and other technologies, made notable strides in the ...